177 related articles for article (PubMed ID: 10775732)
1. Modulation of endometrial steroid receptors and growth regulatory genes by tamoxifen.
Elkas J; Armstrong A; Pohl J; Cuttitta F; Martínez A; Gray K
Obstet Gynecol; 2000 May; 95(5):697-703. PubMed ID: 10775732
[TBL] [Abstract][Full Text] [Related]
2. The effects of tamoxifen on endometrial insulin-like growth factor-1 expression.
Elkas J; Gray K; Howard L; Petit N; Pohl J; Armstrong A
Obstet Gynecol; 1998 Jan; 91(1):45-50. PubMed ID: 9464719
[TBL] [Abstract][Full Text] [Related]
3. The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.
Mourits MJ; Ten Hoor KA; van der Zee AG; Willemse PH; de Vries EG; Hollema H
J Clin Pathol; 2002 Jul; 55(7):514-9. PubMed ID: 12101196
[TBL] [Abstract][Full Text] [Related]
4. [Expression of hormonal receptors (alpha-estrogen, beta-estrogen, progesteron), Ki-67 and P53 in endometrium of tamoxifen treated breast cancer patients].
Negoiţă M; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):834-8. PubMed ID: 22046795
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
[TBL] [Abstract][Full Text] [Related]
6. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
7. The early response of the postmenopausal endometrium to tamoxifen: expression of estrogen receptors, progesterone receptors, and Ki-67 antigen.
Tregón ML; Blümel JE; Tarín JJ; Cano A
Menopause; 2003; 10(2):154-9. PubMed ID: 12627041
[TBL] [Abstract][Full Text] [Related]
8. Does tamoxifen change oestrogen and progesterone receptor expression in the endometrium and breast?
Karck U; Kommoss F
Eur J Cancer; 2000 Sep; 36 Suppl 4():S45-6. PubMed ID: 11056315
[TBL] [Abstract][Full Text] [Related]
9. Expression of steroid receptors, Ki-67, and epidermal growth factor receptor in tamoxifen-treated endometrium.
Hachisuga T; Hideshima T; Kawarabayashi T; Eguchi F; Emoto M; Shirakusa T
Int J Gynecol Pathol; 1999 Oct; 18(4):297-303. PubMed ID: 10542936
[TBL] [Abstract][Full Text] [Related]
10. Effect of tamoxifen on endometrial histology, hormone receptors, and cervical cytology: a prospective study with follow-up.
Leslie KK; Walter SA; Torkko K; Stephens JK; Thompson C; Singh M
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):284-93. PubMed ID: 17721273
[TBL] [Abstract][Full Text] [Related]
11. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate.
Cohen I; Shulman A; Altaras M; Tepper R; Cordoba M; Beyth Y
Gynecol Obstet Invest; 1994; 38(2):127-9. PubMed ID: 7959340
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen.
Miranda SP; Traiman P; Cândido EB; Lages EL; Freitas GF; Lamaita RM; Vidigal PV; da Silva Filho AL
Int J Gynecol Cancer; 2010 Dec; 20(9):1525-30. PubMed ID: 21119367
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptor expression in endometria from women treated with tamoxifen.
Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ
Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688
[TBL] [Abstract][Full Text] [Related]
18. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
19. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
20. Effect of tamoxifen treatment on the endometrial expression of human insulin-like growth factors and their receptor mRNAs.
Roy RN; Gerulath AH; Cecutti A; Bhavnani BR
Mol Cell Endocrinol; 2000 Jul; 165(1-2):173-8. PubMed ID: 10940495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
